STOCKHOLDER ALERT: Monteverde & Associates PC Remind Investors of its Ongoing Investigation Regarding the AcquisitionHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)STOCKHOLDER ALERT: Monteverde & Associates PC Remind Investors of its Ongoing Investigation Regarding the AcquisitionACCESSWIREJanuary 3, 2020ReblogShareTweetShareNEW YORK, NY / ACCESSWIRE / January 3, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:MSB Financial Corp. (NASDAQ:MSBF) ("MSB Financial") related to its sale to Kearny Financial Corp. Under the terms of the Merger, each share of MSB Financial common stock will be converted into the right to receive either (i) $18 in cash or (ii) 1.3 shares of Kearny's common stock for each MSB financial common stock owned. Click here for more information: https://www.monteverdelaw.com/case/msb-financial-corp. It is free and there is no cost or obligation to you. Synthorx, Inc (NASDAQ:THOR) relating to its sale to Sonafi. Under the terms of the Agreement, Synthorx shareholders will receive $68.00 in cash for each share of Synthorx common stock owned. Click here for more information: https://www.monteverdelaw.com/case/synthorx-inc. It is free and there is no cost or obligation to you.Audentes Therapeutics, Inc (NASDAQ:BOLD) related to its sale to Astellas Pharma, Inc. Under the terms of the Agreement, Audentes shareholders will have the right to receive $60.00 in cash for each Audentes common stock owned. Click here for more information: https://www.monteverdelaw.com/case/audentes-therapeutics-inc. It is free and there is no cost or obligation to you.Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.Contact:Juan E. Monteverde, Esq.MONTEVERDE & ASSOCIATES PCThe Empire State Building350 Fifth Ave. Suite 4405New York, NY 10118United States of Americajmonteverde@monteverdelaw.comTel: (212) 971-1341Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.SOURCE: Monteverde & Associates PCView source version on accesswire.com: https://www.accesswire.com/571961/STOCKHOLDER-ALERT-Monteverde-Associates-PC-Remind-Investors-of-its-Ongoing-Investigation-Regarding-the-AcquisitionReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextAllied Esports withdraws planned public offeringAmerican City Business JournalsA new calculator sheds light on high-flying U.S. unicorn price tagsReutersPublic Storage (PSA) Q4 FFO & Revenues Miss Estimates, Up Y/YZacksRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceMarket Recap: Friday, Dec. 13Yahoo Finance Video